Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
alnylam pharmaceuticals
amgen
biotech
boston blog main
boston top stories
cholesterol
fda
inclisiran
national top stories
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
alirocumab
bempedoic acid
corticosteroids
deals
detroit
detroit blog main
detroit top stories
esperion therapeutics
evolocumab
ezetimibe
fluoroquinolones
novartis
pcsk9
praluent
repatha
rna interference
sanofi
statins
the medicines co.
the medicines company
tim mayleben
What
cholesterol
4
×
drug
fda
4
×
medicines
lowering
medco
new
wave
acquire
administration
advisory
agreed
approval
approved
approving
attacks
billion
bringing
brings
cardiovascular
cash
clears
closer
combo
company
compound
deal
dramatically
esperion
esperion’s
favor
filing
food
greatly
health
heart
help
inched
injectable
ldl
Language
unset
Current search:
cholesterol
×
fda
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@theverge.com
8 years ago
FDA panel recommends approving new drug that dramatically lowers cholesterol
